SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

ARO-MAPT-SC Tau ASO Trial (NCT07221344) - Arrowhead Pharmaceuticals

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-aro-mapt-sc-tau-aso
Related Entities
clinical-trials-aro-mapt-sc-tau-aso-nct07221344
Metadata
slugclinical-trials-aro-mapt-sc-tau-aso-nct07221344
entity_typeclinical
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (109)
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Tau ASO Therapy70%
related🧫Cytochrome Therapeutics70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
related🧫Tau ASO Therapy70%
related🧫Cytochrome Therapeutics70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers50%
mentions🧫Microtubule domain analysis in adult axons50%
mentions🧫Tau depletion effects on neuronal development in primary cul50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Extracellular vesicle biomarkers for early AD detection50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🧪HSP90-Tau Disaggregation Complex Enhancement50%
related🧪Noradrenergic-Tau Propagation Blockade50%
related🧪Synaptic Vesicle Tau Capture Inhibition50%
related🧪Mitochondrial-Lysosomal Contact Site Engineering50%
related🧪Lysosomal Membrane Repair Enhancement50%
related🧪Lysosomal Calcium Channel Modulation Therapy50%
related🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease44%
related🔬What are the mechanisms underlying selective vulnerability o40%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
related🔬What are the mechanisms underlying tdp-43 phase separation t40%
related🔬What are the mechanisms underlying blood-brain barrier trans40%
related🔬What are the mechanisms underlying apoe4 structural biology 40%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
related🔬What are the mechanisms underlying digital biomarkers and ai40%
related🔬What are the mechanisms underlying senolytic therapy for age40%
related🔬What are the mechanisms underlying protein aggregation cross40%
related🔬What are the mechanisms underlying rna binding protein dysre40%
related🔬What are the mechanisms underlying synaptic pruning by micro40%
related🔬Analyze circuit-level changes in neurodegeneration using All40%
related🔬What gene expression changes in the aging mouse brain predic40%
related🔬What gene expression changes in the aging mouse brain predic40%
related🔬What gene expression changes in the aging mouse brain predic40%
related🔬What gene expression changes in the aging mouse brain predic40%
related🔬What gene expression changes in the aging mouse brain predic40%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di40%
related🔬Extracellular vesicle biomarkers for early AD detection40%
related🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🔬Senescent cell clearance as neurodegeneration therapy40%
related🔬How does metabolic reprogramming (glucose metabolism shifts,40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub